Tagtreatment failure

Case report: HIV-associated neurocognitive disorder & myelopathy in patient with preserved CD4, but high viral load

C

HIV-associated neurocognitive disorder and HIV-associated myelopathy in a patient with a preserved CD4, but high viral load-a rarely reported phenomenon: a case report and literature review.  Ayele, B.A., Amogne, W. & Gemechu, L. BMC Infect Dis 20, 574 (2020). This case supports the current understanding regarding the persistent occurrence of HIV-associated neurocognitive disorder and HIV...

Early warning system exposes the rise of the gonorrhoea ‘super-superbug’

E

The Age, July19th 2017 – 8:32 AM A critically drug-resistant strain of gonorrhoea dubbed a “super-superbug” has been detected in every Australian state and territory by a new national surveillance system. The National Alert System for Critical Antimicrobial Resistance (CARAlert) identified 1,064 bacteria highly resistant to last-line antibiotics between 17 March 2016 and 31...

Scientists warn that antibiotic-resistant gonorrhoea is on the rise

S

WHO, 07 July 2017 Every day, more than 1 million sexually transmitted infections are acquired worldwide, and each year an estimated 78 million people are infected with gonorrhoea. New data from 77 countries show that antibiotic resistance is making gonorrhoea much harder – and sometimes impossible – to treat. The data has been published in PLOS, in two new scientific articles. Read more...

Treatment guidelines after an outbreak of azithromycin-resistant Neisseria gonorrhoeae in SA

T

The Lancet Infectious Diseases, 17 (2), February 2017 Abstract: Antimicrobial resistance in Neisseria gonorrhoeae is recognised globally as a public health threat. Dual therapy with ceftriaxone and azithromycin has been introduced in Australia and elsewhere as the first-line treatment recommendation for gonorrhoea. While there have been only sporadic reports of ceftriaxone-resistant gonococci...

Two-drug HIV therapy just as effective as three-drug therapy

T

aidsmap/nam, 25 October 2016
SImplification of an antiretroviral treatment to a boosted protease inhibitor and the nucleoside analogue lamivudine (a dual regimen) is highly effective in people switching from a stable three-drug regimen, researchers reported on Monday at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow).
Read more here 

Welcome to SASHA

SASHA is a current awareness service with news and views on various aspects of sexual health and sexuality, from a wide range of sources. These range from credible sources of sexual health and related information, to relevant opinion pieces in the media.

Categories